GENERIC NAME OF MEDICINAL PRODUCT:

A. Lignocaine Hydrochloride Injection IP 2%w/v

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Lignocaine Hydrochloride Injection IP 2%w/v
Each ml contains:
Lignocaine Hydrochloride IP……………..21.3mg
Sodium Chloride IP…………………………..6.0mg
Methylparaben IP (as preservative)…..1.0mg
Water for Injection IP……………………….q.s

THERAPEUTIC INDICATION:

Lignocaine Injection belongs to two groups of medicines known as local anaesthetics and antiarrhythmic drugs. Local anaesthetics stop pain and feeling in the area around where it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heart beats to normal.

DIRECTION OF USE:

For Intravenous use only.
See enclosed leaflet for further information.

CAUTION AND SCHEDULE:

CAUTION: Do not use in case of any foreign particulate matter is observed inside the vial.
To be administered after a test done with adequate precaution to cope with any adverse reactions.
Maximum 10 withdrawals.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
To be administered after a test done with adequate precaution to cope with any adverse reactions.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
SCHEDULE: SCHEDULE 'H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store below 30°C. Protect from light. Do not freeze.
DOSAGE: As directed by the Physician.

Lignocaine Hydrochloride Injection IP 2%w/v Technical Specification:

Product Name:Lignocaine Hydrochloride Injection IP
Brand Name:Generic
Strength:2%w/v
Dosage Form:Liquid Injection
Packing:30ml,  50ml  Vial
Route of Administration:For I.V. use only
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Product Permission, Stability Studies, GMP
Therapeutic use:Local Anaesthetic, Antiarrhythmic (Class IB)
Indication: Lignocaine Injection belongs to two groups of medicines known as local anaesthetics and antiarrhythmic drugs. Local anaesthetics stop pain and feeling in the area around where it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heart beats to normal.
Storage:Store below 30°C. Protect from light. Do not freeze.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Lignocaine Hydrochloride Injection IP 2%w/v 

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Lignocaine Hydrochloride Injection IP 2%w/v
    Each ml contains:
    Lignocaine Hydrochloride IP……………..21.3mg
    Sodium Chloride IP…………………………..6.0mg
    Methylparaben IP (as preservative)…..1.0mg
    Water for Injection IP……………………….q.s

THERAPEUTIC INDICATION:

Lignocaine Injection belongs to two groups of medicines known as local anaesthetics and antiarrhythmic drugs. Local anaesthetics stop pain and feeling in the area around where it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heart beats to normal.

DIRECTION OF USE:

For Intravenous use only.
See enclosed leaflet for further information.

CAUTION AND SCHEDULE:

CAUTION: Do not use in case of any foreign particulate matter is observed inside the vial.
To be administered after a test done with adequate precaution to cope with any adverse reactions.
Maximum 10 withdrawals.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
To be administered after a test done with adequate precaution to cope with any adverse reactions.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.

SCHEDULE: SCHEDULE ‘H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store below 30°C. Protect from light. Do not freeze.

DOSAGE: As directed by the Physician.